Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weixue Huang

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Enzyme and Microbial Technology|May 16, 2021
Structural insights into xylanase mutant 254RL1 for improved activity and lower pH optimumLa Xiang, Meixing Wang, Lian Wu, et al.
Acta Pharmacologica Sinica|September 13, 2023
Neuronal K<sup>+</sup>-Cl<sup>-</sup> cotransporter KCC2 as a promising drug target for epilepsy treatmentErin McMoneagle, Jin Zhou, Shiyao Zhang, et al.
Cellular & Molecular Biology Letters|July 19, 2006
Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinomaShan Liu, Lijie Ma, Weixue Huang, et al.
Bioorganic & Medicinal Chemistry|March 15, 2024
Discovery of LHF418 as a new potent SOS1 PROTAC degraderHuifan Li, Minxue Chai, Yihan Chen, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitorsXiaorong Qiu, Rong Liu, Huan Ling, et al.
Molecular Biology Reports|March 21, 2008
Identification of a novel human lactate dehydrogenase gene LDHAL6A, which activates transcriptional activities of AP1(PMA)Xinya Chen, Xiuting Gu, Yuxi Shan, et al.
European Journal of Medicinal Chemistry|January 31, 2025
Discovery of the first potent ROR1 degrader for the treatment of non-small cell lung cancerJinlin Li, Lin Li, Caiyun Hou, et al.
Journal of Medicinal Chemistry|April 8, 2024
Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 InhibitorsPengpeng Niu, Yanxin Tao, Guohao Lin, et al.
European Journal of Pharmacology|June 8, 2024
Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive reviewWujun Geng, Holly Thomas, Zhiyuan Chen, et al.
Journal of Medicinal Chemistry|May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase InhibitorYulin Mao, Meiying Zhang, Hao Tang, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Enzyme and Microbial Technology|May 16, 2021
Structural insights into xylanase mutant 254RL1 for improved activity and lower pH optimumLa Xiang, Meixing Wang, Lian Wu, et al.
Acta Pharmacologica Sinica|September 13, 2023
Neuronal K<sup>+</sup>-Cl<sup>-</sup> cotransporter KCC2 as a promising drug target for epilepsy treatmentErin McMoneagle, Jin Zhou, Shiyao Zhang, et al.
Cellular & Molecular Biology Letters|July 19, 2006
Decreased expression of the human carbonyl reductase 2 gene HCR2 in hepatocellular carcinomaShan Liu, Lijie Ma, Weixue Huang, et al.
Bioorganic & Medicinal Chemistry|March 15, 2024
Discovery of LHF418 as a new potent SOS1 PROTAC degraderHuifan Li, Minxue Chai, Yihan Chen, et al.
European Journal of Medicinal Chemistry|March 13, 2024
Discovery of 5-aminopyrido[2,3-d]pyrimidin-7(8H)-one derivatives as new hematopoietic progenitor kinase 1 (HPK1) inhibitorsXiaorong Qiu, Rong Liu, Huan Ling, et al.
Molecular Biology Reports|March 21, 2008
Identification of a novel human lactate dehydrogenase gene LDHAL6A, which activates transcriptional activities of AP1(PMA)Xinya Chen, Xiuting Gu, Yuxi Shan, et al.
European Journal of Medicinal Chemistry|January 31, 2025
Discovery of the first potent ROR1 degrader for the treatment of non-small cell lung cancerJinlin Li, Lin Li, Caiyun Hou, et al.
Journal of Medicinal Chemistry|April 8, 2024
Design and Synthesis of Novel Macrocyclic Derivatives as Potent and Selective Cyclin-Dependent Kinase 7 InhibitorsPengpeng Niu, Yanxin Tao, Guohao Lin, et al.
European Journal of Pharmacology|June 8, 2024
Mechanisms of acquired resistance to HER2-Positive breast cancer therapies induced by HER3: A comprehensive reviewWujun Geng, Holly Thomas, Zhiyuan Chen, et al.
Journal of Medicinal Chemistry|May 29, 2026
Discovery of a Potent, Selective and In Vivo Active Aurora A PROTAC Degrader from a Promiscuous Kinase InhibitorYulin Mao, Meiying Zhang, Hao Tang, et al.
Pageof 4